Cancer Drug Maker Wants 10th Circuit Panel Or En Banc Court To Rehear Preemption
DENVER — Genentech Inc. on June 12 petitioned the 10th Circuit U.S. Court of Appeals to rehear or rehear en banc arguments that claims about the company underfilling vials of the...To view the full article, register now.
Already a subscriber? Click here to view full article